MarginsXMarginsX
Home › Markets › DFPH

Starling Oncology, Inc. (DFPH)

DFPH is quoted over the counter, not listed on an exchange. Starling Oncology, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · December 11, 2025
$2.01
No trades since Dec 11, 2025; later closes repeat the last quote
1-year return
+11.7%
Market cap
The company also trades on Nasdaq as STLN; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerDFPH, quoted over the counter
SEC CIK0001799191
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codeServices-Offices & Clinics of Doctors of Medicine
Business addressCerritos, CA
Incorporated inDE

Warning signs

Cash runway
Cash-flow positive
$36.9M cash at September 30, 2026
Share count, 1 year
+3.7%
2025-11-06 to 2026-11-03 · +38.3% over 3 years
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
-$122K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"In connection with the preparation of the condensed consolidated financial statements as of September 30, 2026, the Company conducted an evaluation as to whether there were conditions and events, considered in the aggregate, which raised substantial doubt as to its ability to continue as a going concern within one year after the date of the issuance of such financial statements."
10-Q 2026-11-06
Cash and burn$36.9M cash; operating cash flow $5.8M a quarter.Report 2026-09-30
Shares outstanding101,991,024 (2026-11-03); 98,381,340 a year earlier; 73,748,979 three years earlier.Cover page 2026-11-03
Reverse splits, 3 years1; latest on 2025-03-25Source 2025-03-25
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2026-11-13
AuditorBDO USA, P.C., Costa Mesa, California, United StatesPCAOB Form AP 2026-03-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $2.7M, sold $2.8M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$169.8M-$15.7M$10.1M$36.9M$72.5M$620.4M10-Q 2026-11-06
Q2 2026
2026-06-30
$161.3M-$9.8M$11.9M$41.1M$79.9M$587.2M10-Q 2026-08-06
Q1 2026
2026-03-31
$147.4M-$2.5M-$2.2M$30.3M$78.6M$545.8M10-Q 2026-05-07
Q4 2025
2025-12-31
$142.0M-$7.5M$3.2M$33.6M$77.4M$502.7M10-K 2026-03-12
Q3 2025
2025-09-30
$136.6M-$16.5M-$12.6M$27.7M$76.2M$461.0M10-Q 2026-11-06
Q2 2025
2025-06-30
$119.8M-$17.0M-$10.2M$30.3M$75.0M$424.4M10-Q 2026-08-06
Q1 2025
2025-03-31
$104.4M-$19.6M-$5.0M$39.7M$73.9M$403.2M10-Q 2026-05-07
Q4 2024
2024-12-31
$100.3M-$13.2M$4.0M$49.7M$93.1M$393.4M10-K 2026-03-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-08-13
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K/A2026-11-12
Latest proxyDEFA14A2026-04-30

Source: SEC EDGAR submissions feed, 552 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier